Skip to main content
Equibles

4559 · ZERIA PHARMCEUTICAL CO., LTD. · Financials

Use 4559 with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research 4559.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
2,088 JPY +4 (+0.19%) At close · Nov 13
Rebalance outlook locked
Market Cap
92.04B JPY
Shares
44.08M
Volume · Nov 13 90.6K Avg daily vol (3M) 150.33K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
89.16B +2.1%
FY2026 Revenue FY2022–FY2026
Net Income
8.45B -14.9%
FY2026 Net Income FY2022–FY2026
Gross Margin
73.11% -0.1pp
FY2026 Gross Margin FY2022–FY2026
Operating Margin
13.88% -0.1pp
FY2026 Operating Margin FY2022–FY2026
Operating Cash Flow
9.96B -23%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2026 FY2025 FY2024 FY2023 FY2022
JPY 89.16B 87.31B 75.73B 68.38B 59.53B
JPY 23.98B 23.35B 20.22B 18.89B 17.38B
JPY 65.18B 63.96B 55.5B 49.49B 42.15B
JPY 12.37B 12.2B 9.62B 9.01B 6.37B
JPY 11.2B 12.62B 9.51B 7.27B 5.72B
JPY 2.78B 2.65B 1.81B 1.07B 1.75B
JPY 8.45B 9.94B 7.73B 6.2B 3.96B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 9.15B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.